Natural History of Marburg Virus Infection to Support Medical Countermeasure Development

Jason E. Comer, Trevor Brasel, Shane Massey, David W. Beasley, Chris M. Cirimotich, Daniel C. Sanford, Ying Liang Chou, Nancy A. Niemuth, Joseph Novak, Carol L. Sabourin, Michael Merchlinsky, James P. Long, Eric J. Stavale, Daniel N. Wolfe

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, recognizes that the evaluation of medical countermeasures under the Animal Rule requires well-characterized and reproducible animal models that are likely to be predictive of clinical benefit. Marburg virus (MARV), one of two members of the genus Marburgvirus, is characterized by a hemorrhagic fever and a high case fatality rate for which there are no licensed vaccines or therapeutics available. This natural history study consisted of twelve cynomolgus macaques challenged with 1000 PFU of MARV Angola and observed for body weight, temperature, viremia, hematology, clinical chemistry, and coagulation at multiple time points. All animals succumbed to disease within 8 days and exhibited signs consistent with those observed in human cases, including viremia, fever, systemic inflammation, coagulopathy, and lymphocytolysis, among others. Additionally, this study determined the time from exposure to onset of disease manifestations and the time course, frequency, and magnitude of the manifestations. This study will be instrumental in the design and development of medical countermeasures to Marburg virus disease.

Original languageEnglish (US)
Article number2291
Issue number10
StatePublished - Oct 2022


  • FDA
  • MARV
  • Marburg virus
  • filovirus
  • macaques
  • natural history study
  • virus

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology


Dive into the research topics of 'Natural History of Marburg Virus Infection to Support Medical Countermeasure Development'. Together they form a unique fingerprint.

Cite this